FDA Inspection 903661 — Nexus Pharmaceuticals, LLC

Nexus Pharmaceuticals, LLC — FEI 3005191225

The FDA completed an inspection of Nexus Pharmaceuticals, LLC on Nov 5, 2014 in Lincolnshire, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 5, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lincolnshire, IL (United States)

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
241921 CFR 211.198(a)Complaint Handling Procedure